← Back to Search

Low Somatic Symptom Score for Depression

N/A

Waitlist Available

Research Sponsored by Spectrum Health - Lakeland

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

patients 18-65, patients with diagnosis of MDD, PHQ-9 score > 10 at screening and baseline

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 8 weeks

Awards & highlights

Study Summary

This trial will investigate whether osteopathic manipulative therapy (OMT) can help relieve symptoms of depression. 1x/week for 8 weeks, 30 min/appointment. Patients will fill out depression symptom questionnaires before and after the trial.

Eligible Conditions

Depression

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 8 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~8 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Therapeutic procedure

Trial Design

2Treatment groups

Active Control

Group I: Low Somatic Symptom ScoreActive Control1 Intervention

Patients meeting PHQ-9 (Patient health Questionnaire)-9 with score greater than 10 with Somatic Symptom Score less than 7. These patients will receive the OMT treatment protocol and PHQ-9 and SSS scales will be recorded at 0, 4, and 8 weeks.

Group II: High Somatic Symptom ScoreActive Control1 Intervention

Patients meeting PHQ-9 (Patient health Questionnaire)-9 with score greater than 10 with Somatic Symptom Score 8 or greater These patients will receive the OMT treatment protocol and PHQ-9 and SSS scales will be recorded at 0, 4, and 8 weeks.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Spectrum Health - LakelandLead Sponsor

12 Previous Clinical Trials

1,774 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical research encompass geriatric participants?

"This clinical trial stipulates that patients must be aged 18 and over, with a maximum age limit of 65."

Answered by AI

Is this research actively seeking participants?

"Per the clinicaltrials.gov website, this study's recruitment window is still open. It was first advertised on March 12th 2021 and has gone through a series of updates since then; its most recent edition occurred on October 25th 2022."

Answered by AI

Who meets the criteria for enrollment in this medical trial?

"This medical research is in search of 100 melancholic individuals, aged 18 to 65. Eligible patients should have been diagnosed with Major Depressive Disorder and possess a PHQ-9 score higher than 10 both at the screening period and baseline."

Answered by AI

What is the total participant count for this research program?

"Affirmative. The information available on clinicaltrials.gov reveals that this medical experiment is currently seeking participants. It was initially posted on March 12th 2021 and last modified October 25th 2022, with the aim of enrolling 100 people from one location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

OMT as an Adjunctive Treatment in MDD

2021. "OMT as an Adjunctive Treatment in MDD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05065580.